A first clinical trial testing the use of an H₂S donor after heart attack

Media formats available:

Hemodynamic valve deterioration in transcatheter aortic valves vs. surgical aortic valves
Hemodynamic valve deterioration in transcatheter aortic valves vs. surgical aortic valves
ACC.22
Hemodynamic valve deterioration in transcatheter aortic valves vs. surgical aortic valves
- Megan Coylewright, MD
EHR-based intervention improves quality care for patients with HF
EHR-based intervention improves quality care for patients with HF
ACC.22
EHR-based intervention improves quality care for patients with HF
- Tariq Ahmad, MD
Reductions in LVOT gradients, NYHA class and NT-proBNP with cardiac myosin inhibitor in HCM
Reductions in LVOT gradients, NYHA class and NT-proBNP with cardiac myosin inhibitor in HCM
ACC.22
Reductions in LVOT gradients, NYHA class and NT-proBNP with cardiac myosin inhibitor in HCM
- Florian Rader, MD
Beginning of an era: Treatment of elevated Lp(a)
Beginning of an era: Treatment of elevated Lp(a)
ACC.22
Beginning of an era: Treatment of elevated Lp(a)
- Steven Nissen, MD

PACE-CME